Serotonin is a Common Thread Linking Different Classes of Antidepressants

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• The precise pathology of depression remains unclear, prompting research beyond the traditional monoamine hypothesis.
• While selective serotonin reuptake inhibitors (SSRIs) are common, their variable efficacy drives the search for novel antidepressant therapies, including ketamine, linked to synaptic plasticity and neurogenesis.
• Existing evidence suggests diverse antidepressant classes may influence serotonin levels, warranting further investigation.

Approach:

• This study investigated the effects of acute antidepressant challenges on hippocampal serotonin levels in mice.
• Serotonin was measured using in vivo voltammetry to assess extracellular concentrations.

Key Points:

• Pseudo-equivalent doses of different antidepressant classes similarly elevated ambient serotonin levels.
• Despite distinct pharmacodynamics, including variations in Uptake 1 and 2, SERT trafficking, and histamine modulation, the net effect on extracellular serotonin was comparable.
• These findings highlight a conserved mechanism of action among effective antidepressants.

Conclusions:

• Serotonin emerges as a unifying factor linking clinically effective antidepressants, regardless of their primary mechanism of action.
• These findings support the integration of the monoamine hypothesis with newer theories involving synaptic plasticity and neurogenesis.
• The study highlights extracellular serotonin as a common neurobiological target for diverse antidepressant therapies.